Clinical Trials Browser

INDUSTRY × Advanced Solid Tumor × sintilimab × Clear all

NCT03903705 2025-04-06

: A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT03758001 2023-02-22

First in Human Study of IBI101 in Chinese Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumor